BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15704867)

  • 1. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
    Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
    Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
    Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
    Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam monotherapy for the treatment of infants with epilepsy.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ; Kang HC; Kim HD; Lee JS
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use.
    Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
    J Child Neurol; 2005 Jul; 20(7):590-4. PubMed ID: 16159526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.